Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sports doping detection study of nandrolone, recombinant LH, and recombinant hCG in healthy men
ACTRN12608000181303Phase 4Recruiting
- Sponsor
- Sydney South West Area Health Authority
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nandrolone, lutropin alfa and recombinant human chorionic gonadotrophin (2 arms), sponsored by Sydney South West Area Health Authority. Primary endpoints: Bioassay measurement of luteinizing hormone levels in blood and urine and Bioassay measurement of testosterone in blood and urine. Started Nov 2004; status: recruiting.
02
Drugs
nandrolonelutropin alfarecombinant human chorionic gonadotrophin
Beyond the preview
Go deeper on ACTRN12608000181303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000181303.